Current status of immunologic recurrent pregnancy loss

Area of Science:

• Reproductive Immunology
• Maternal-Fetal Medicine

Background:

• Normal pregnancy involves managing maternal immune responses to both self (autoimmune) and foreign (alloimmune) antigens.
• Dysregulation of these maternal immune responses can lead to recurrent pregnancy loss (RPL), impacting 2-5% of couples.
• While known factors explain half of RPL cases, immunological causes are suspected in 80% of unexplained RPL.

Purpose of the Study:

• To explore the role of autoimmune and alloimmune factors in recurrent pregnancy loss.
• To review diagnostic methods and experimental therapies for immune-mediated RPL.
• To highlight the need for evidence-based treatment strategies.

Main Methods:

• Review of diagnostic techniques including HLA typing, mixed lymphocyte culture, and antiphospholipid antibody tests.
• Examination of experimental therapies such as leukocyte immunization, IVIg, and anticoagulants.
• Emphasis on the importance of randomized placebo-controlled trials for treatment efficacy.

Main Results:

• Immunological factors are implicated in a significant majority of unexplained recurrent pregnancy loss.
• Various diagnostic assays exist to differentiate auto- and alloimmune responses.
• Experimental therapies show promise but require further validation through rigorous clinical trials.

Conclusions:

• Immune system modulation plays a critical role in successful pregnancy.
• Accurate diagnosis of auto- and alloimmune factors is essential for effective RPL management.
• Future research and clinical trials are crucial for establishing optimal treatment protocols for immune-mediated RPL.